Inventor · disambiguated record
Jeffrey Jackson
Also filed as: JACKSON JEFFREY · JACKSON JEFFREY R · JACKSON JEFFREY RICHARD
11 granted patents·14 pending applications·38 citations·filing 1997–2025
87Inventor score
Top patents by PatentIndex Score
25 records- 0193US12049503B2Treatment of LAG-3 positive tumorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jul 30, 2024·4 cites·30 claims
- 0290US11807686B2Treatment of LAG-3 positive tumorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 7, 2023·5 cites·38 claims
- 0380US2025043006A1Treatment of lag-3 positive tumorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0478US2024174749A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0575US12448460B2Treatment of lung cancer using an anti-fucosyl-GM1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Oct 21, 2025·0 cites·10 claims
- 0674US2023111786A1Compositions comprising a combination of an anti-lag-3 antibody, a pd-1 pathway inhibitor, and an immunotherapeutic agentBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0768US2025197494A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0867US2025163152A1Compositions comprising a combination of an anti-lag-3 antibody, a pd-1 pathway inhibitor, and an immunotherapeutic agentBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0965US2021340250A1Compositions comprising a combination of an anti-lag-3 antibody, a pd-1 pathway inhibitor, and an immunotherapeutic agentBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1063US5922546AHuman disintegrin metalloprotease KUZ geneSMITHKLINE BEECHAM CORP·Filed 1997·Granted Jul 13, 1999·19 cites·20 claims
- 1161US2021363242A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1258US2019389965A1Treatment of lung cancer using an anti-fucosyl-gm1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1354US2004096888A1Human pelota homologSMITHKLINE BEECHAM CORP·Filed 2003·Application pending·0 cites
- 1453US2009291442A1Hspa1a as a marker for sensitivity to ksp inhibitorsSMITHKLINE BEECHAM CORP·Filed 2007·Application pending·0 cites
- 1551US6657047B2Human Pelota homologSMITHKLINE BEECHAM CORP·Filed 2001·Granted Dec 2, 2003·0 cites·26 claims
- 1647US2017247466A1Treatment of lung cancer using an anti-fucosyl-gm1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1746US2002123500A1Use of CSAIDTM compounds as inhibitors of angiogenesisSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 1845US2007015154A1Differentially expressed nucleic acids that correlate with ksp expressionSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 1943US6245544B1Human serum inducible kinase (Snk)SMITHKLINE BEECHAM CORP·Filed 2000·Granted Jun 12, 2001·0 cites·2 claims
- 2041US6372741B1Use of CSAID™ compounds as inhibitors of angiogenesisSMITHKLINE BEECHAM CORP·Filed 1997·Granted Apr 16, 2002·4 cites·11 claims
- 2140US2002127227A1RHAMM antagonist antibodiesSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 2239US6342584B1Human pelota homologSMITHKLINE BEECHAM CORP·Filed 1999·Granted Jan 29, 2002·2 cites·3 claims
- 2338US5925539AHuman pelota homologSMITHKLINE BEECHAM CORP·Filed 1998·Granted Jul 20, 1999·2 cites·2 claims
- 2438US5922853AHuman pelota homologSMITHKLINE BEECHAM CORP·Filed 1997·Granted Jul 13, 1999·2 cites·6 claims
- 2524US6063609AHuman serum inducible kinase (Snk)SMITHKLINE BEECHAM CORP·Filed 1998·Granted May 16, 2000·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey Jackson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →